Keeps Pharma (256940) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Keeps Pharma is dated 2024-03-29; the most recent is 2026-05-07. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | SELL | 임원퇴임 | 김정호 Kim Jeong-ho | president | -248.4K | ₩7,260 | +9.1% | ₩1.8B ($1.3M) |
| 2026-03-01 | BUY | 신규선임 | 김형규 Kim Hyeong-gyu | moving | 3.0K | ₩7,690 | +6.8% | ₩23M ($16K) |
| 2024-11-01 | BUY | 신규선임 | 최정주 Jeongju Choi | Managing Director | 19.8K | ₩5,990 | +37.1% | ₩119M ($83K) |
| 2024-03-29 | SELL | 임원퇴임 | 노관민 Noh Gwan-min | thanks | -26.5K | ₩6,950 | -18.1% | ₩184M ($128K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Keeps Pharma. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.